Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MONTRÉAL, 06 mai 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») (TSX : LOVE) (OTCQX : LOVFF) (FRA : 8CB0), producteur verticalement intégré de cannabis de...
-
Cannara completes acquisition of Medican Organic and appoints Nicholas Sosiak as COO, strengthening operational expertise and growth strategy.
-
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
-
U.S. Launch of MYQORZO® (aficamten) in Late January Met with Strong Demand; Over 275 HCPs Prescribed MYQORZO to an estimated 680 Patients in Q1 ACACIA-HCM Met Dual Primary Endpoints of KCCQ and...
-
OAKLAND, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Biosphere, a U.S.-based pioneer in biomanufacturing technology, today announced the award of an Other Transaction Authority (OTA) agreement with a...
-
Company advances its leadership in MASH with clinical-stage, genetically targeted siRNA asset from Arrowhead PharmaceuticalsPrecision approach targets patients who have a mutation in the PNPLA3 gene,...
-
Announced positive topline induction data from Part A of the Phase 2 SKYLINE trial of SPY001, demonstrating best-in-class efficacy potential and a safety profile consistent with the α4β7 class ...
-
Nu-Tek BioSciences to showcase data, products at ESACT 2026 annual meeting in Salzburg, Austria.
-
New Sector-Focused YieldBOOSTTM ETFs Targeting Biotech, Financials, Technology, and 20+ Year Treasuries Begin Trading May 5, 2026 NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- GraniteShares, a global...
-
Trial Met Dual Primary Endpoints of KCCQ and Maximal Exercise Performance With Consistent Positive Findings Across Key Secondary Endpoints Company to Host Conference Call and Webcast Tuesday May 5 at...